
[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - SAT0181 Low dose interleukin-2 combined with tocilizumab selectively increases regulatory t cells helping refractory rheumatoid arthritis patients achieve remission more rapidly
Sheng-Xiao, Z, Xiao-Wen, M, Xiao-Qing, L, Miao, M, Xiao-Yan, W, Hong-Qing, N, Cai-Hong, W, Xiao-Feng, LLangue:
english
DOI:
10.1136/annrheumdis-2017-eular.3611
Fichier:
PDF, 141 KB
english